On April 22, 2026, the Japanese Industrial Standards Committee（JISC）officially implemented the JIS T 0101:2026 standard, adding the ‘72-hour high-temperature high-humidity zero-point drift accelerated aging test’（85℃/85%RH）, which applies to all medical blood pressure, intracranial pressure, and ventilator pressure sensors exported to Japan. This requirement directly affects the manufacturing, export, and certification of medical pressure sensors for the Japanese market, and relevant companies need to reassess their compliance pathways and supply chain response capabilities.

Event Overview

The Japanese Industrial Standards Committee（JISC）announced the official implementation of the JIS T 0101:2026 version on April 22, 2026. The new version of the standard adds Clause 7.3.5, the ‘72-hour high-temperature high-humidity zero-point drift accelerated aging test’, with test conditions of 85℃、85%RH for 72 hours, applicable to all medical blood pressure sensors, intracranial pressure sensors, and ventilator pressure sensors exported to Japan. This test has not been included in China’s current mandatory standard GB 9706.1-2020, so most domestic manufacturers must commission Japan-designated laboratories（such as JQA）to conduct retesting, with the certification cost per batch expected to increase by about 2800 USD and the lead time extended by about 3 weeks.

Which Segments Are Affected

Direct Trading Enterprises

Trading companies exporting medical pressure sensors to the Japanese market will be directly restricted by the new testing requirements. Since test reports from the country of origin are not accepted by the Japanese side, exported products must undergo supplementary JIS-specific testing, resulting in delays in the completeness of customs clearance documents, longer order delivery cycles, and potential contractual performance risks.

Processing and Manufacturing Enterprises

Manufacturers engaged in the design, assembly, or calibration of medical pressure sensors need to adjust their product validation processes accordingly. If the existing zero-point stability design does not cover long-term drift control under 85℃/85%RH conditions, they will face the need for design rework, component reselection, or process optimization, especially affecting companies using non-automotive-grade MEMS chips or standard packaging processes.

Supply Chain Service Enterprises

Third-party organizations providing services such as export certification agency, localized testing coordination, and JIS compliance consulting will see a short-term increase in business demand. However, because they rely on the scheduling and assessment standards of Japan-designated laboratories（such as JQA）, their service capabilities are constrained by overseas resource supply, creating risks of delayed response and quotation fluctuations.

Channel Distribution Enterprises

Distributors acting as agents for imported Japanese-brand pressure sensors or supplying Japanese-funded medical equipment manufacturers need to reconfirm whether the products they sell have completed full certification under JIS T 0101:2026. If upstream suppliers fail to update certificates in time, it may cause end customers to fail acceptance inspection, affecting access qualifications for Japanese medical institutions or OEM manufacturers.

What Key Points Should Relevant Enterprises or Practitioners Focus On, and How Should They Respond Now

Confirm the Certification Status of Products Corresponding to Current Orders

Check whether medical pressure sensors shipped to Japan after April 22, 2026 have completed all tests under JIS T 0101:2026, especially the newly added 72-hour high-temperature high-humidity zero-point drift item; for certified products, verify the validity period of the certificate and the version number of the testing basis to avoid mistakenly using old-version reports.

Prioritize Contact with Japan-Designated Laboratories to Obtain Scheduling and Technical Clarification

Proactively contact JISC-recognized laboratories such as JQA to clarify test sample requirements, estimated cycle time, and cost structure; focus on practical details such as the zero-point drift judgment threshold, initial calibration method, and data recording frequency to reduce repeated submissions caused by misunderstanding.

Assess the Environmental Tolerance Margin of Key Components

For existing mass-produced models, sort out the technical specifications of pressure sensing dies, signal conditioning circuits, and packaging materials, and compare typical parameter drift values under 85℃/85%RH; for designs without sufficient margin, small-batch validation testing can be initiated to reserve a transition window for subsequent mass-production switching.

Differentiate the Applicable Boundaries Between the New and Old Standards to Avoid Policy Misinterpretation

JIS T 0101:2026 only governs medical pressure sensors exported to Japan and does not automatically extend to other JIS medical device standards or markets such as CE and FDA; for similar products sold domestically or exported to other markets, GB 9706.1-2020 or the current standards of the target country still apply, and no simultaneous upgrade is required.

Editorial Viewpoint / Industry Observation

From an industry perspective, the newly added zero-point drift accelerated aging test in JIS T 0101:2026 is more appropriately understood as a structural reinforcement of Japan’s long-term reliability verification system for medical sensors, rather than simply a stricter index. In analysis, this test focuses on the degradation behavior of zero-point stability under the coupled effects of high-temperature and high-humidity dual stress, reflecting increased Japanese attention to failure modes such as long-term powered operation of equipment in clinical scenarios and insufficient environmental adaptability. What is more noteworthy at present is that this requirement has not yet formed a coordinated trend in international standards and remains a regional technical barrier in the short term; however, if similar verification logic is introduced in subsequent revisions of the IEC 60601-2-XX series standards or ISO 80601-2-x, it may drive the evolution of testing paradigms in mainstream global markets.

Conclusion

The implementation of JIS T 0101:2026 is not a generalized regulatory upgrade, but a precise requirement targeting the long-term performance retention capability of medical pressure sensors under specific environmental stress. At present, it means higher requirements for the precision of compliance response and the depth of technical verification within supply chains exporting to Japan, but it does not yet constitute a disruptive constraint on the industry’s overall technology roadmap. It is currently more appropriate to understand it as a refined adjustment of a regional market access threshold, and relevant enterprises should respond pragmatically based on specific products, specific markets, and specific certification pathways, avoiding overinterpretation or blind investment in universal modifications.

Source Information

Main source: announcement document of the Japanese Industrial Standards Committee（JISC）dated April 22, 2026（JIS T 0101:2026）; items to be continuously observed: subsequent implementation details, test report templates, and summaries of common nonconformities to be issued by designated laboratories such as JQA.